These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

441 related articles for article (PubMed ID: 36874010)

  • 1. Nanoparticle drug delivery systems for synergistic delivery of tumor therapy.
    Chen D; Liu X; Lu X; Tian J
    Front Pharmacol; 2023; 14():1111991. PubMed ID: 36874010
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recent advances in co-delivery nanosystems for synergistic action in cancer treatment.
    Carvalho BG; Vit FF; Carvalho HF; Han SW; de la Torre LG
    J Mater Chem B; 2021 Feb; 9(5):1208-1237. PubMed ID: 33393582
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
    Pérez-Herrero E; Fernández-Medarde A
    Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent Advances in Nanoparticle-Based Co-Delivery Systems for Cancer Therapy.
    Al Bostami RD; Abuwatfa WH; Husseini GA
    Nanomaterials (Basel); 2022 Aug; 12(15):. PubMed ID: 35957103
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gene/paclitaxel co-delivering nanocarriers prepared by framework-induced self-assembly for the inhibition of highly drug-resistant tumors.
    Wang C; Guan W; Peng J; Chen Y; Xu G; Dou H
    Acta Biomater; 2020 Feb; 103():247-258. PubMed ID: 31846802
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inorganic nanoparticle-based advanced cancer therapies: Promising combination strategies.
    Amaldoss MJN; Yang JL; Koshy P; Unnikrishnan A; Sorrell CC
    Drug Discov Today; 2022 Dec; 27(12):103386. PubMed ID: 36182068
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug and gene co-delivery systems for cancer treatment.
    Yang Z; Gao D; Cao Z; Zhang C; Cheng D; Liu J; Shuai X
    Biomater Sci; 2015 Jul; 3(7):1035-49. PubMed ID: 26221938
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced anti-tumor efficacy by co-delivery of doxorubicin and paclitaxel with amphiphilic methoxy PEG-PLGA copolymer nanoparticles.
    Wang H; Zhao Y; Wu Y; Hu YL; Nan K; Nie G; Chen H
    Biomaterials; 2011 Nov; 32(32):8281-90. PubMed ID: 21807411
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nanocarriers for delivery of siRNA and co-delivery of siRNA and other therapeutic agents.
    Zhao J; Feng SS
    Nanomedicine (Lond); 2015 Jul; 10(14):2199-228. PubMed ID: 26214357
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improvement of conventional anti-cancer drugs as new tools against multidrug resistant tumors.
    Dallavalle S; Dobričić V; Lazzarato L; Gazzano E; Machuqueiro M; Pajeva I; Tsakovska I; Zidar N; Fruttero R
    Drug Resist Updat; 2020 May; 50():100682. PubMed ID: 32087558
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Natural Compounds: Co-Delivery Strategies with Chemotherapeutic Agents or Nucleic Acids Using Lipid-Based Nanocarriers.
    Teixeira PV; Fernandes E; Soares TB; Adega F; Lopes CM; Lúcio M
    Pharmaceutics; 2023 Apr; 15(4):. PubMed ID: 37111802
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Opportunities and challenges for co-delivery nanomedicines based on combination of phytochemicals with chemotherapeutic drugs in cancer treatment.
    Gao Q; Feng J; Liu W; Wen C; Wu Y; Liao Q; Zou L; Sui X; Xie T; Zhang J; Hu Y
    Adv Drug Deliv Rev; 2022 Sep; 188():114445. PubMed ID: 35820601
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Co-delivery of Docetaxel and Disulfonate Tetraphenyl Chlorin in One Nanoparticle Produces Strong Synergism between Chemo- and Photodynamic Therapy in Drug-Sensitive and -Resistant Cancer Cells.
    Gaio E; Conte C; Esposito D; Miotto G; Quaglia F; Moret F; Reddi E
    Mol Pharm; 2018 Oct; 15(10):4599-4611. PubMed ID: 30148955
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Co-delivery of siRNA and therapeutic agents using nanocarriers to overcome cancer resistance.
    Creixell M; Peppas NA
    Nano Today; 2012 Aug; 7(4):367-379. PubMed ID: 26257819
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CaCO
    Yang X; Sun Y; Zhang H; Liu F; Chen Q; Shen Q; Kong Z; Wei Q; Shen JW; Guo Y
    Nanoscale; 2024 Apr; 16(14):6876-6899. PubMed ID: 38506154
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Co-delivery of 5-fluorouracil and miRNA-34a mimics by host-guest self-assembly nanocarriers for efficacious targeted therapy in colorectal cancer patient-derived tumor xenografts.
    Xu J; Zhang G; Luo X; Wang D; Zhou W; Zhang Y; Zhang W; Chen J; Meng Q; Chen E; Chen H; Song Z
    Theranostics; 2021; 11(5):2475-2489. PubMed ID: 33500737
    [No Abstract]   [Full Text] [Related]  

  • 17. Redox-responsive nanocarriers for drug and gene co-delivery based on chitosan derivatives modified mesoporous silica nanoparticles.
    Lin JT; Liu ZK; Zhu QL; Rong XH; Liang CL; Wang J; Ma D; Sun J; Wang GH
    Colloids Surf B Biointerfaces; 2017 Jul; 155():41-50. PubMed ID: 28407530
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combinations of chemo-, immuno-, and gene therapies using nanocarriers as a multifunctional drug platform.
    Hopkins C; Javius-Jones K; Wang Y; Hong H; Hu Q; Hong S
    Expert Opin Drug Deliv; 2022 Oct; 19(10):1337-1349. PubMed ID: 35949105
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multifunctional co-transport carriers based on cyclodextrin assembly for cancer synergistic therapy.
    Yi S; Liao R; Zhao W; Huang Y; He Y
    Theranostics; 2022; 12(6):2560-2579. PubMed ID: 35401819
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent advances in delivery of drug-nucleic acid combinations for cancer treatment.
    Li J; Wang Y; Zhu Y; Oupický D
    J Control Release; 2013 Dec; 172(2):589-600. PubMed ID: 23624358
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.